Delivery Order SPE2DB22D3301-SPE2DB25FY5DS

Award Date 5/22/25
Potential Completion Date 6/13/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,179.51 firm fixed-price delivery order is for the drug LYNPARZA 100 mg tablets. The contract has an ultimate completion date of January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,567.60, is for the delivery of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product. The contract has a completion date of May 2, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,519.62 firm fixed-price delivery order covers the procurement of 4567090102 ! LYNPARZA 100 MG TABLET UU 120S, with a period of performance through February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,499.34 firm fixed-price delivery order is for the supply of the drug LYNPARZA 150 MG TABLET UU 60S to support military healthcare programs. The contract has an ultimate completion date of April 10, 2025 and was awarded on March 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,499.34 firm fixed-price delivery order is for the supply of LYNPARZA 150 MG TABLET UU 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with a ceiling value of $10,567.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product. The contract has a period of performance extending through June 4, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,212.02 fixed-price delivery order is for the supply of LYNPARZA 150 MG TABLET UU 120S, a prescription pharmaceutical product. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a $10,567.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product, with an ultimate completion date of March 3, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lynparza 100 mg tablets, a prescription medication. The contract has a firm fixed price of $42,078.48 and a completion date of May 22, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999.00, which...
This federal contract award, valued at $31,558.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of LYNPARZA 100 MG TABLET UU 120S, with a period of performance ending on April 30, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY5DS
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract, worth $10,519.62, is for the delivery of LYNPARZA 100 MG TABLET UU 120S, a pharmaceutical product. The contract has a completion date of June 13, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a key supplier of medical and pharmaceutical products to federal agencies, particularly the DLA, through various contract vehicles. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support service with a performance period through December 2026. This contract award appears to be a specific delivery order under that larger IDC, supplying the DLA, U.S. Coast Guard, and other government agencies with necessary pharmaceutical products to support military and veteran healthcare programs.

Generated 8/24/25, 1:03 AM